International Patent: 3-((5-(1H-INDAZOL-4-YL)-8,9-DIHYDRO-10H-7-OXA-1,3,6,10-TETRAAZACYCLOHEPTA[DE]NAP HTHALEN-10-YL)METHYL)PYRIDIN-2-AMINE DERIVATIVES AS RAS INHIBITORS FOR THE TREATMENT OF CANCER

GENEVA, Oct. 22 -- KESTREL THERAPEUTICS INC. filed a patent application (US2026/011345) for “3-((5-(1H-INDAZOL-4-YL)-8,9-DIHYDRO-10H-7-OXA-1,3,6,10-TETRAAZACYCLOHEPTA[DE]NAP HTHALEN-10-YL)METHYL)PYRIDIN-2-AMINE DERIVATIVES AS RAS INHIBITORS FOR THE TREATMENT OF CANCER”. With publication no. WO/2026/156118, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07D 498/16

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....